{
    "Trade/Device Name(s)": [
        "Elecsys\u00ae Troponin T STAT Assay",
        "Roche Elecsys\u00ae Troponin T STAT"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K051752",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040733"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "July 11, 2005",
    "Summary Letter Received Date": "June 29, 2005",
    "Submission Date": "June 28, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Troponin T"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Li-heparin tube",
        "Na-citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche Elecsys family of immunoassay analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Sandwich immunoassay",
        "Streptavidin microparticle-based"
    ],
    "Methodologies": [
        "Immunoassay",
        "Electrochemiluminescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys Troponin T STAT electrochemiluminescent immunoassay for quantitative determination of troponin T in serum and plasma",
    "Indications for Use Summary": "Quantitative in vitro measurement of troponin T in human serum and plasma to aid in diagnosis and risk stratification of acute coronary syndrome, cardiac risk in chronic renal failure, and selection of therapy in patients with elevated cardiac troponin T levels",
    "fda_folder": "Clinical Chemistry"
}